Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age29-18
SponsorThe Children's Hospital of Zhejiang University School of Medicine

About this trial

The goal of this clinical trial is to evaluate the application of intravenous contrast-enhanced ultrasound examination in children with intra-abdominal diseases that require clear diagnoses. The main questions it aims to answer are:

* Is intravenous contrast-enhanced ultrasound helpful for the diagnosis of intra-abdominal diseases in children? * What medical problems do participants have when participating in intravenous contrast-enhanced ultrasound examination? * How can ultrasound doctors conduct intravenous contrast-enhanced ultrasound examinations in a standardized manner? Researchers will performing intravenous contrast-enhanced ultrasound examinations on participants and collecting research subjects to establish a multicenter clinical data database.

Participants will:

* Perform abdominal ultrasound examination to assess the condition. * At least conduct one intravenous contrast-enhanced ultrasound examination. Based on the result of the contrast examination, decide whether to conduct another examination. * Keep a diary of their symptoms and therapeutic process in 30 days.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 29 days to 18 years old;

The clinical diagnosis was abdominal space-occupying lesions, blunt abdominal trauma, ascites of unknown cause, and children with suspected abdominal disease but other examinations could not identify the cause.

Disqualifiers

Allergic to sulfur hexafluoride or other components;

Heart disease with right-to-left shunt/severe pulmonary hypertension /uncontrolled systemic hypertension/respiratory failure/heart failure/severe arrhythmia;

Electrocardiogram, echocardiography or clinical manifestations of myocardial ischemia;

Patients with severe blood system diseases or infectious diseases;

Trial population

Patients in Children's Hospital Affiliated to Zhejiang University School of Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Shenzhen Children's Hospital, West China Hospital of Sichuan University, Children's Hospital of Chongqing Medical University, Tianjin Children's Hospital, Xi 'an Children's Hospital, Yuying Children's Hospital Affiliated to Wenzhou Medical University, Kunming Children's Hospital.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • contrast-enhanced ultrasound examination

    Device

    to evaluate the the application of contrast-enhanced ultrasound examination in children with intra-abdominal diseases that require clear diagnoses aged from 29 days to 18 years old

  • SonoVue®

    Drug

    perform contrast enhanced ultrasound (CEUS) using Sonovue as the contrast agent

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

sensitivity

to calculate the sensitivity of venous contrast-enhanced ultrasound examination in children

Time frame
Thirty days after the last venous ultrasound contrast examination
2

specificity

to calculate the specificity of venous contrast-enhanced ultrasound examination in children

Time frame
Thirty days after the last venous ultrasound contrast examination
3

Positive predictive value

to calculate the positive predictive value of venous contrast-enhanced ultrasound examination in children

Time frame
Thirty days after the last venous ultrasound contrast examination
4

Negative predictive value

to calculate the negative predictive value of venous contrast-enhanced ultrasound examination in children

Time frame
Thirty days after the last venous ultrasound contrast examination

Secondary outcomes

Other outcomes

1

adverse event rate

to calculate the adverse event rate of venous contrast-enhanced ultrasound examination in children

Time frame
Thirty days after the last venous ultrasound contrast examination

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

The Children's Hospital of Zhejiang University School of Medicine

Lead sponsor

Shenzhen Children's Hospital

Collaborator

Children's Hospital of Chongqing Medical University

Collaborator

Tianjin Children's Hospital

Collaborator

Kunming Children's Hospital

Collaborator

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborator

West China Hospital

Collaborator

Yuying Children's Hospital of Wenzhou Medical University

Collaborator

Xian Children's Hospital

Collaborator